Voloridge Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Sell |
91,811
-44,924
| -33% | -$6.82M | 0.05% | 440 |
|
|
2025
Q1 | $20.6M | Sell |
136,735
-19,839
| -13% | -$2.99M | 0.08% | 350 |
|
|
2024
Q4 | $28.9M | Buy |
156,574
+80,918
| +107% | +$14.9M | 0.1% | 260 |
|
|
2024
Q3 | $14.9M | Buy |
75,656
+68,458
| +951% | +$13.5M | 0.05% | 459 |
|
|
2024
Q2 | $1.49M | Buy |
+7,198
| New | +$1.49M | 0.01% | 993 |
|
|
2023
Q3 | – | Sell |
-49,688
| Closed | -$10.4M | – | 1413 |
|
|
2023
Q2 | $10.4M | Buy |
+49,688
| New | +$10.4M | 0.05% | 454 |
|
|
2022
Q4 | – | Sell |
-217,836
| Closed | -$42.9M | – | 1467 |
|
|
2022
Q3 | $42.9M | Sell |
217,836
-37,674
| -15% | -$7.41M | 0.23% | 119 |
|
|
2022
Q2 | $54.7M | Buy |
255,510
+118,618
| +87% | +$25.4M | 0.28% | 91 |
|
|
2022
Q1 | $38.9M | Buy |
136,892
+80,856
| +144% | +$23M | 0.22% | 117 |
|
|
2021
Q4 | $21.1M | Buy |
56,036
+55,116
| +5,991% | +$20.8M | 0.12% | 248 |
|
|
2021
Q3 | $380K | Buy |
+920
| New | +$380K | ﹤0.01% | 1503 |
|
|
2020
Q3 | – | Sell |
-14,660
| Closed | -$2.56M | – | 1285 |
|
|
2020
Q2 | $2.56M | Buy |
+14,660
| New | +$2.56M | 0.03% | 535 |
|
|
2020
Q1 | – | Sell |
-27,727
| Closed | -$4.24M | – | 1137 |
|
|
2019
Q4 | $4.24M | Buy |
+27,727
| New | +$4.24M | 0.08% | 315 |
|
|
2019
Q2 | – | Sell |
-5,044
| Closed | -$733K | – | 800 |
|
|
2019
Q1 | $733K | Buy |
+5,044
| New | +$733K | 0.02% | 569 |
|
|
2017
Q4 | – | Sell |
-8,190
| Closed | -$885K | – | 496 |
|
|
2017
Q3 | $885K | Buy |
+8,190
| New | +$885K | 0.02% | 332 |
|
|
2016
Q2 | – | Sell |
-8,114
| Closed | -$616K | – | 322 |
|
|
2016
Q1 | $616K | Buy |
+8,114
| New | +$616K | 0.01% | 267 |
|
|
2015
Q2 | – | Sell |
-22,525
| Closed | -$1.79M | – | 318 |
|
|
2015
Q1 | $1.79M | Buy |
+22,525
| New | +$1.79M | 0.09% | 191 |
|